These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

236 related items for PubMed ID: 18403600

  • 1. A novel mechanism for CCR4 in the regulation of macrophage activation in bleomycin-induced pulmonary fibrosis.
    Trujillo G, O'Connor EC, Kunkel SL, Hogaboam CM.
    Am J Pathol; 2008 May; 172(5):1209-21. PubMed ID: 18403600
    [Abstract] [Full Text] [Related]

  • 2. The role of the Th2 CC chemokine ligand CCL17 in pulmonary fibrosis.
    Belperio JA, Dy M, Murray L, Burdick MD, Xue YY, Strieter RM, Keane MP.
    J Immunol; 2004 Oct 01; 173(7):4692-8. PubMed ID: 15383605
    [Abstract] [Full Text] [Related]

  • 3. The in vivo fibrotic role of FIZZ1 in pulmonary fibrosis.
    Liu T, Yu H, Ullenbruch M, Jin H, Ito T, Wu Z, Liu J, Phan SH.
    PLoS One; 2014 Oct 01; 9(2):e88362. PubMed ID: 24516640
    [Abstract] [Full Text] [Related]

  • 4. CCL17 drives fibroblast activation in the progression of pulmonary fibrosis by enhancing the TGF-β/Smad signaling.
    Wang QR, Liu SS, Min JL, Yin M, Zhang Y, Zhang Y, Tang XN, Li X, Liu SS.
    Biochem Pharmacol; 2023 Apr 01; 210():115475. PubMed ID: 36870575
    [Abstract] [Full Text] [Related]

  • 5. Protective role of NKT cells and macrophage M2-driven phenotype in bleomycin-induced pulmonary fibrosis.
    Grabarz F, Aguiar CF, Correa-Costa M, Braga TT, Hyane MI, Andrade-Oliveira V, Landgraf MA, Câmara NOS.
    Inflammopharmacology; 2018 Apr 01; 26(2):491-504. PubMed ID: 28779430
    [Abstract] [Full Text] [Related]

  • 6. Increased levels of Gab1 and Gab2 adaptor proteins skew interleukin-4 (IL-4) signaling toward M2 macrophage-driven pulmonary fibrosis in mice.
    Guo X, Li T, Xu Y, Xu X, Zhu Z, Zhang Y, Xu J, Xu K, Cheng H, Zhang X, Ke Y.
    J Biol Chem; 2017 Aug 25; 292(34):14003-14015. PubMed ID: 28687632
    [Abstract] [Full Text] [Related]

  • 7. Macrophage derived chemokine (CCL22), thymus and activation-regulated chemokine (CCL17), and CCR4 in idiopathic pulmonary fibrosis.
    Yogo Y, Fujishima S, Inoue T, Saito F, Shiomi T, Yamaguchi K, Ishizaka A.
    Respir Res; 2009 Aug 29; 10(1):80. PubMed ID: 19715610
    [Abstract] [Full Text] [Related]

  • 8. Immunosuppressive effects of CCL17 on pulmonary antifungal responses during pulmonary invasive aspergillosis.
    Carpenter KJ, Hogaboam CM.
    Infect Immun; 2005 Nov 29; 73(11):7198-207. PubMed ID: 16239514
    [Abstract] [Full Text] [Related]

  • 9. MMP28 promotes macrophage polarization toward M2 cells and augments pulmonary fibrosis.
    Gharib SA, Johnston LK, Huizar I, Birkland TP, Hanson J, Wang Y, Parks WC, Manicone AM.
    J Leukoc Biol; 2014 Jan 29; 95(1):9-18. PubMed ID: 23964118
    [Abstract] [Full Text] [Related]

  • 10. Myeloid-specific disruption of tyrosine phosphatase Shp2 promotes alternative activation of macrophages and predisposes mice to pulmonary fibrosis.
    Tao B, Jin W, Xu J, Liang Z, Yao J, Zhang Y, Wang K, Cheng H, Zhang X, Ke Y.
    J Immunol; 2014 Sep 15; 193(6):2801-11. PubMed ID: 25127857
    [Abstract] [Full Text] [Related]

  • 11. Paired immunoglobulin-like receptor-B inhibits pulmonary fibrosis by suppressing profibrogenic properties of alveolar macrophages.
    Karo-Atar D, Moshkovits I, Eickelberg O, Königshoff M, Munitz A.
    Am J Respir Cell Mol Biol; 2013 Apr 15; 48(4):456-64. PubMed ID: 23258232
    [Abstract] [Full Text] [Related]

  • 12. Neotuberostemonine attenuates bleomycin-induced pulmonary fibrosis by suppressing the recruitment and activation of macrophages.
    Xiang J, Cheng S, Feng T, Wu Y, Xie W, Zhang M, Xu X, Zhang C.
    Int Immunopharmacol; 2016 Jul 15; 36():158-164. PubMed ID: 27144994
    [Abstract] [Full Text] [Related]

  • 13. Essential roles of the CC chemokine ligand 3-CC chemokine receptor 5 axis in bleomycin-induced pulmonary fibrosis through regulation of macrophage and fibrocyte infiltration.
    Ishida Y, Kimura A, Kondo T, Hayashi T, Ueno M, Takakura N, Matsushima K, Mukaida N.
    Am J Pathol; 2007 Mar 15; 170(3):843-54. PubMed ID: 17322370
    [Abstract] [Full Text] [Related]

  • 14. Markers of macrophage differentiation in experimental silicosis.
    Misson P, van den Brûle S, Barbarin V, Lison D, Huaux F.
    J Leukoc Biol; 2004 Nov 15; 76(5):926-32. PubMed ID: 15292275
    [Abstract] [Full Text] [Related]

  • 15. Activation of alveolar macrophages via the alternative pathway in herpesvirus-induced lung fibrosis.
    Mora AL, Torres-González E, Rojas M, Corredor C, Ritzenthaler J, Xu J, Roman J, Brigham K, Stecenko A.
    Am J Respir Cell Mol Biol; 2006 Oct 15; 35(4):466-73. PubMed ID: 16709958
    [Abstract] [Full Text] [Related]

  • 16. IL20Rb aggravates pulmonary fibrosis through enhancing bone marrow derived profibrotic macrophage activation.
    Zhu J, Jiang Q, Gao S, Xia Q, Zhang H, Liu B, Zhao R, Jiang H, Li X, Xu A, Zhou H, Xu Z, Yang C.
    Pharmacol Res; 2024 May 15; 203():107178. PubMed ID: 38583686
    [Abstract] [Full Text] [Related]

  • 17. Reduced locomotor activity and exploratory behavior in CC chemokine receptor 4 deficient mice.
    Ambrée O, Klassen I, Förster I, Arolt V, Scheu S, Alferink J.
    Behav Brain Res; 2016 Nov 01; 314():87-95. PubMed ID: 27469058
    [Abstract] [Full Text] [Related]

  • 18. Lrp5/β-Catenin Signaling Controls Lung Macrophage Differentiation and Inhibits Resolution of Fibrosis.
    Sennello JA, Misharin AV, Flozak AS, Berdnikovs S, Cheresh P, Varga J, Kamp DW, Budinger GR, Gottardi CJ, Lam AP.
    Am J Respir Cell Mol Biol; 2017 Feb 01; 56(2):191-201. PubMed ID: 27668462
    [Abstract] [Full Text] [Related]

  • 19. CC chemokine receptor 4 modulates Toll-like receptor 9-mediated innate immunity and signaling.
    Ishii M, Hogaboam CM, Joshi A, Ito T, Fong DJ, Kunkel SL.
    Eur J Immunol; 2008 Aug 01; 38(8):2290-302. PubMed ID: 18624303
    [Abstract] [Full Text] [Related]

  • 20. GM-CSF regulates bleomycin-induced pulmonary fibrosis via a prostaglandin-dependent mechanism.
    Moore BB, Coffey MJ, Christensen P, Sitterding S, Ngan R, Wilke CA, McDonald R, Phare SM, Peters-Golden M, Paine R, Toews GB.
    J Immunol; 2000 Oct 01; 165(7):4032-9. PubMed ID: 11034414
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 12.